CJ-12406
- Generic Name
- CJ-12406
Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects
- First Posted Date
- 2011-12-12
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 86
- Registration Number
- NCT01489774
- Locations
- 🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath